Brief: Brickell Biotech Inc - R. Michael Carruthers, CFO And Principal Accounting Officer, Will Be Resigning
Nov 24 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH INC - R. MICHAEL CARRUTHERS, CO'S CFO AND
PRINCIPAL ACCOUNTING OFFICER, WILL BE RESIGNING FROM THESE
POSITIONS WITH CO
* BRICKELL BIOTECH INC - ALBERT (BERT) N. MARCHIO, II HAS
BEEN
APPOINTED BY BOARD TO SUCCEED CARRUTHERS AS CFO, EFFECTIVE DEC
1, 2020
Source text for Eikon: ID:
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx